Meksibel

General characteristics. Structure:

Active ingredient: 125 mg of a meksidol.

Pharmacological properties:

Pharmacodynamics. Increases resistance of an organism to a stress, influence of the major disturbing factors and to kislorodozavisimy morbid conditions (to shock, a hypoxia, ischemia, disturbance of cerebral circulation, intoxication alcohol and antipsychotic drugs). Improves memory and working capacity. Eliminates alarm, fear, tension, concern, improves the emotional status.

Possesses neurotyre-tread action, stimulates recovery and adaptive processes in a brain at a craniocereberal injury. Promotes acceleration of evolution intracerebral, including posttraumatic, hemorrhages.

At the persons who transferred an acute disorder of cerebral circulation as a part of complex therapy exerts beneficial effect on processes of a mass transfer of oxygen in a brain.

Indications to use:

As a part of complex therapy at the acute disorder of cerebral circulation, disturbances of cerebral circulation caused by a craniocereberal injury; distsirkulyatorny encephalopathy, easy cognitive frustration against the background of atherosclerotic defeat of vessels of a brain, intoxications, dysmnesias and intellectual insufficiency at elderly people, alarming frustration at neurotic states, an abstinence syndrome at alcoholism in the presence of neurosis-like and vegeto-vascular disturbances, acute poisoning with neuroleptics, treatment of trophic ulcers of venous genesis, an ulitis, a periodontal disease, periodontosis, acute it is purulent - necrotic processes of an abdominal cavity (acute pancreatitis, peritonitis).

Route of administration and doses:

Drug is accepted inside on 0,25-0,5 g/days in 2-3 receptions; the maximum daily dose – 0,6-0,8 g. Duration of treatment makes - 2-6 weeks; for stopping of alcoholic abstinence - 5-7 days.

The mode of dosing is selected individually, depending on severity of a disease. Treatment is stopped gradually, reducing a dose within 2-3 days.

Features of use:

Patients with the arterial pressure more than 180/100 mm Hg, the krizovy course of arterial hypertension need preliminary correction of arterial hypertension and sedative therapy, and also control of arterial pressure during performing therapy.

Side effects:

Nausea, dryness in a mouth, diarrhea, drowsiness, allergic reactions; at prolonged use - nausea, a meteorism; sleep disorders (drowsiness or disturbance of backfilling).

Interaction with other medicines:

Strengthens effect of benzodiazepine anxiolytics, antiepileptic (carbamazepine), protivoparkinsonichesky (levodopa) medicines, nitrates. Reduces toxic effects of ethanol.

Contraindications:

Acute disorders of function of a liver and/or kidneys, hypersensitivity to drug, children's age up to 18 years, pregnancy, a lactation.

Overdose:

Symptoms: sleep disorders (sleeplessness, in certain cases – drowsiness);

Treatment, as a rule, is not required as symptoms disappear independently within a day.

Issue conditions:

According to the recipe

Packaging:

Tablets, coated, on 125 mg in packaging No. 30 (10x3 in blister strip packagings).